Double maintains 2 strategies that include DNLI - Denali Therapeutics, Inc.
Current Value
$14.151 Year Return
Current Value
$14.151 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 73.23% | $4.85B | 0.35% |
GNOM | 69.52% | $40.65M | 0.5% |
IBB | 68.04% | $5.22B | 0.45% |
ARKG | 66.53% | $944.78M | 0.75% |
PBE | 62.38% | $214.12M | 0.58% |
PTH | 61.29% | $96.56M | 0.6% |
IWC | 60.81% | $766.88M | 0.6% |
PINK | 60.15% | $131.52M | 0.5% |
IWO | 59.39% | $11.36B | 0.24% |
BBH | 59.18% | $327.42M | 0.35% |
FBT | 59.00% | $994.71M | 0.56% |
IWM | 58.68% | $63.95B | 0.19% |
XPH | 58.66% | $136.58M | 0.35% |
VTWO | 58.59% | $12.07B | 0.07% |
SCHA | 57.57% | $16.91B | 0.04% |
KJUL | 57.11% | $113.35M | 0.79% |
GSSC | 57.08% | $538.65M | 0.2% |
KJAN | 57.04% | $305.13M | 0.79% |
ISCG | 56.66% | $645.00M | 0.06% |
IWN | 56.44% | $11.10B | 0.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KR | -0.14% | $44.68B | +24.17% | 1.89% |
TEF | 0.40% | $27.20B | +8.80% | 6.44% |
EXC | 0.42% | $43.84B | +12.45% | 3.59% |
AMT | 0.47% | $99.10B | +8.59% | 3.09% |
CYCN | 0.53% | $9.37M | +2.39% | 0.00% |
SYPR | 0.55% | $37.69M | +21.48% | 0.00% |
OCFT | -0.80% | $265.28M | +232.26% | 0.00% |
CPSH | -0.97% | $27.45M | +8.62% | 0.00% |
FUBO | -1.01% | $1.01B | +121.80% | 0.00% |
GFI | 1.05% | $18.61B | +31.67% | 2.75% |
KMB | 1.10% | $45.57B | +1.99% | 3.58% |
DUK | 1.11% | $90.12B | +12.74% | 3.61% |
MKTX | -1.18% | $8.01B | -1.42% | 1.39% |
MSIF | 1.20% | $715.25M | +28.42% | 7.05% |
PULM | 1.58% | $23.82M | +239.64% | 0.00% |
AEP | 1.69% | $54.28B | +9.80% | 3.61% |
TMUS | 1.74% | $272.69B | +46.81% | 1.27% |
NEUE | -1.83% | $62.05M | +13.56% | 0.00% |
VSTA | 1.94% | $326.82M | +11.64% | 0.00% |
TRVG | 2.01% | $106.63M | +117.76% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTH | 0.03% | $1.53B | 0.07% |
SMB | 0.07% | $269.10M | 0.07% |
FXE | -0.08% | $525.40M | 0.4% |
LDUR | -0.15% | $849.09M | 0.5% |
UGA | 0.30% | $73.47M | 0.97% |
DFNM | -0.49% | $1.53B | 0.17% |
DBE | 0.52% | $48.48M | 0.77% |
MLN | 0.75% | $532.71M | 0.24% |
SGOV | 1.00% | $45.91B | 0.09% |
SHYD | 1.02% | $318.05M | 0.35% |
IBTP | 1.09% | $129.44M | 0.07% |
UNG | 1.20% | $371.83M | 1.06% |
KRBN | -1.22% | $160.09M | 0.85% |
UDN | 1.35% | $137.74M | 0.78% |
IEI | 1.39% | $16.09B | 0.15% |
TFLO | -1.44% | $7.06B | 0.15% |
USDU | -1.45% | $173.44M | 0.5% |
IBTI | 1.45% | $995.39M | 0.07% |
SHM | 1.53% | $3.37B | 0.2% |
STPZ | 1.59% | $446.46M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -40.24% | $361.41M | 1.43% |
VIXY | -38.28% | $109.64M | 0.85% |
TAIL | -37.37% | $140.49M | 0.59% |
IVOL | -11.81% | $353.94M | 1.02% |
TPMN | -11.79% | $31.54M | 0.65% |
JMST | -11.07% | $3.65B | 0.18% |
XONE | -9.64% | $603.24M | 0.03% |
GBIL | -8.98% | $6.17B | 0.12% |
ULST | -8.51% | $637.77M | 0.2% |
FXY | -7.56% | $838.61M | 0.4% |
TBLL | -6.89% | $2.46B | 0.08% |
SPTS | -6.27% | $5.76B | 0.03% |
XHLF | -6.17% | $1.46B | 0.03% |
BIL | -5.93% | $45.95B | 0.1356% |
CTA | -5.88% | $1.05B | 0.76% |
WEAT | -5.19% | $115.83M | 0.28% |
BSMW | -5.00% | $102.62M | 0.18% |
BILZ | -4.85% | $876.85M | 0.14% |
UTWO | -4.48% | $387.71M | 0.15% |
SCHO | -4.01% | $10.87B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -12.66% | $22.95B | +20.67% | 1.12% |
CME | -9.68% | $98.74B | +28.80% | 3.84% |
LITB | -9.55% | $21.28M | -72.45% | 0.00% |
MO | -9.20% | $97.80B | +26.35% | 6.94% |
AQB | -7.14% | $2.96M | -61.58% | 0.00% |
AIFU | -6.68% | $9.85M | -95.03% | 0.00% |
VSA | -5.26% | $7.04M | -49.24% | 0.00% |
ED | -4.09% | $36.75B | +5.26% | 3.28% |
FMTO | -4.01% | $45.74M | -99.96% | 0.00% |
VHC | -3.46% | $34.69M | +74.89% | 0.00% |
VZ | -3.44% | $183.32B | +8.02% | 6.21% |
SRRK | -2.84% | $2.92B | +115.29% | 0.00% |
BTCT | -2.81% | $25.35M | +93.08% | 0.00% |
STG | -2.80% | $27.05M | -37.35% | 0.00% |
PSQH | -2.68% | $89.26M | -49.87% | 0.00% |
T | -2.53% | $196.66B | +57.98% | 4.07% |
NOC | -2.37% | $67.51B | -0.35% | 1.76% |
PPC | -2.30% | $11.21B | +41.54% | 0.00% |
K | -2.25% | $28.49B | +32.17% | 2.77% |
ZCMD | -2.14% | $32.45M | -11.38% | 0.00% |
Yahoo
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Yahoo
SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the first quarter ended March 31, 2025, and provided business highlights. “The completion of our BLA submission for tividenofusp alfa represents a pivotal milestone—not only in our commitment to delivering a potentially transformative therapy to individuals living with Hunter syndrome, but also in Denali’s evolution as a fully integrated, late-stage developme
Yahoo
Let us look at some drug/biotech stocks, NVO, PCRX, RARE, ACAD and DNLI, which are poised to beat on first-quarter 2025 earnings.
Yahoo
Denali stock up as it begins rolling BLA submission with the FDA for accelerated approval of tividenofusp alfa for the treatment of Hunter syndrome.
Finnhub
SOUTH SAN FRANCISCO - Denali Therapeutics Inc. , today announced that the company's initiation of a rolling submission of a biologics license application for accelerated approval of tividenofusp alfa...
Yahoo
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval for tividenofusp alfaProductive collaboration continues under START for an accelerated development and approval path for DNL126 SOUTH SAN FRANCISCO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announ
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BEAM | 60.94% | $1.73B | -27.49% | 0.00% |
RCKT | 59.47% | $724.54M | -71.26% | 0.00% |
NTLA | 58.83% | $836.43M | -69.14% | 0.00% |
NRIX | 58.14% | $721.19M | -38.57% | 0.00% |
ACLX | 57.41% | $3.22B | +10.72% | 0.00% |
ARWR | 57.12% | $2.12B | -38.64% | 0.00% |
RGNX | 56.67% | $433.39M | -46.03% | 0.00% |
ATXS | 56.31% | $225.17M | -57.69% | 0.00% |
IDYA | 55.54% | $1.52B | -58.32% | 0.00% |
CRSP | 54.62% | $3.14B | -34.78% | 0.00% |
CLDX | 53.14% | $1.33B | -49.67% | 0.00% |
CDXS | 52.43% | $207.94M | -33.42% | 0.00% |
OCUL | 52.39% | $1.14B | +14.35% | 0.00% |
CRNX | 52.33% | $2.92B | -39.88% | 0.00% |
KYMR | 52.14% | $1.95B | -15.67% | 0.00% |
VRDN | 51.30% | $1.03B | -13.74% | 0.00% |
TWST | 51.12% | $1.80B | -35.27% | 0.00% |
KRYS | 51.04% | $3.77B | -20.42% | 0.00% |
EYPT | 50.83% | $393.60M | -54.31% | 0.00% |
ABCL | 50.81% | $602.94M | -46.56% | 0.00% |